Position Paper on Critical Care Pharmacy Services (Executive Summary): 2020 Update

 

Position Paper on Critical Care Pharmacy Services (Executive Summary): 2020 Update

 

by Lat, Ishaq; Paciullo, Christopher; Daley, Mitchell J.; MacLaren, Robert; Bolesta, Scott; McCann, Jennifer; Stollings, Joanna L.; Gross, Kendall; Foos, Sarah A.; Roberts, Russel J.; Acquisto, Nicole M.; Taylor, Scott; Bentley, Michael; Jacobi, Judith; Meyer, Tricia A.

 

Critical Care Medicine: September 2020 - Volume 48 - Issue 9 - p 1375-1382

 

Objectives: 

Provide a multiorganizational statement to update the statement from a paper in 2000 about critical care pharmacy practice and makes recommendations for future practice.

Design: 

The Society of Critical Care Medicine, American College of Clinical Pharmacy Critical Care Practice and Research Network, and the American Society of Health-Systems Pharmacists convened a joint task force of 15 pharmacists representing a broad cross-section of critical care pharmacy practice and pharmacy administration, inclusive of geography, critical care practice setting, and roles. The Task Force chairs reviewed and organized primary literature, outlined topic domains, and prepared the methodology for group review and consensus. A modified Delphi method was used until consensus (> 66% agreement) was reached for each practice recommendation. Previous position statement recommendations were reviewed and voted to either retain, revise, or retire. Recommendations were categorized by level of ICU service to be applicable by setting, and grouped into five domains: patient care, quality improvement, research and scholarship, training and education, and professional development.

Main Results: 

There are 82 recommendation statements: forty-four original recommendations and 38 new recommendation statements. Thirty-four recommendations were made for patient care, primarily relating to critical care pharmacist duties and pharmacy services. In the quality improvement domain, 21 recommendations address the role of the critical care pharmacist in patient and medication safety, clinical quality programs, and analytics. Nine recommendations were made in the domain of research and scholarship. Ten recommendations are in the domain of training and education and eight recommendations regarding professional development.

Conclusions: 

The statements recommended by this taskforce delineate the activities of a critical care pharmacist and the scope of pharmacy services within the ICU. Effort should be made from all stakeholders to implement the recommendations provided, with continuous effort toward improving the delivery of care for critically ill patients.